乙酰肝素酶在原发性肝细胞肝癌中的表达及临床意义  被引量:5

EXPRESSION AND CLINICAL SIGNIFICANCE OF HEPARANASE IN PRIMARY HEPATOCELLULAR CARCINOMA

在线阅读下载全文

作  者:田志宏[1] 王顺祥[2] 张凤瑞[2] 

机构地区:[1]山西省人民医院普外科东区,山西太原030001 [2]河北医科大学第四医院肝胆外科,河北石家庄050011

出  处:《河北医科大学学报》2007年第3期172-174,共3页Journal of Hebei Medical University

摘  要:目的研究乙酰肝素酶在原发性肝细胞肝癌中的表达及临床意义。方法免疫组织化学S-P法。结果原发性肝癌45例中乙酰肝素酶表达阳性26例(57.8%);在高分化(6/17)、无肝内转移(12/28)和无淋巴结转移(14/31)的肝癌中乙酰肝素酶阳性表达率明显低于低分化(20/28)、肝内转移(14/17)和淋巴结转移(12/14)的肝癌(P<0.05)。结论乙酰肝素酶可能是原发性肝细胞肝癌的生物学行为和预后的重要标记物,阳性表达者可能恶性程度高和预后不良。Objective To investigate the expression and clinical significances of heparanase (Hpa) in primary hepatocellular carcinoma tissue. Methods Immunohistochemistry of avidinbiotin complex was used in this study. Results The positive rate of Hpa was 57.8% in 45 cases with primary hepatocellular carcinoma. The positive rates of Hpa were significantly lower in cases of well differentiated cancer (6/17), cases without intrahepatic metastasis (12/28), and cases without lymph node metastasis (14/31)than that in the cases of carcinomas of poor differentiation(20/28) ( P 〈0.05), cases with intrahepatic metastasis(14/17) ( P 〈0.05), and cases with lymph node metastasis(12/14)( P 〈0.05). Conclusion Hpa is an important marker reflecting the biological behaviors and prognosis of primary hepatocellular carcinoma. The positive expression of Hpa suggests higher maligance and poor prognosis.

关 键 词: 肝细胞 乙酰肝素酶 免疫组织化学 

分 类 号:R735.7[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象